Notable concerns that warrant closer review
Net revenues grew 7.3% to $40.6 billion, driven by higher combustible tobacco pricing and increased smoke-free product volume, although cigarette volumes declined.. Significant one-time charges and gains heavily impacted diluted EPS in 2025, with a notable absence of a large 2024 impairment charge affecting year-over-year comparisons.. Contingent liabilities from tobacco/nicotine litigation could lead to significant financial impact, although the company believes it has valid defenses. Management has not concluded that a loss is probable or estimated a range of loss for these cases.. Europe segment revenue increased 9.05%